Related Experiment Video
Updated: Aug 9, 2025
Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
The Application of Ethnomedicine in Modulating Megakaryocyte Differentiation and Platelet Counts
Fei Yang1,2, Jia Lai1,2, Junzhu Deng3
1School of Pharmacy, Southwest Medical University, Luzhou 646000, China.
Abstract:
Megakaryocytes (MKs), a kind of functional hematopoietic stem cell, form platelets to maintain platelet balance through cell differentiation and maturation. In recent years, the incidence of blood diseases such as thrombocytopenia has increased, but these diseases cannot be fundamentally solved. The platelets produced by MKs can treat thrombocytopenia-associated diseases in the body, and myeloid differentiation induced by MKs has the potential to improve myelosuppression and erythroleukemia. Currently, ethnomedicine is extensively used in the clinical treatment of blood diseases, and the recent literature has reported that many phytomedicines can improve the disease status through MK differentiation. This paper reviewed the effects of botanical drugs on megakaryocytic differentiation covering the period 1994-2022, and information was obtained from PubMed, Web of Science and Google Scholar. In conclusions, we summarized the role and molecular mechanism of many typical botanical drugs in promoting megakaryocyte differentiation in vivo, providing evidence as much as possible for botanical drugs treating thrombocytopenia and other related diseases in the future.
Insights
Botanical drugs promote megakaryocyte differentiation, offering a promising avenue for treating blood disorders like thrombocytopenia. This review highlights phytomedicines
Area of Science:
- Hematology
- Pharmacology
- Cell Biology
Background:
- Megakaryocytes (MKs) are crucial for platelet production and maintaining hemostasis.
- Blood diseases like thrombocytopenia are increasing, with limited fundamental treatment options.
- Phytomedicines are increasingly recognized for their therapeutic potential in hematological conditions.
Purpose of the Study:
- To review the effects of botanical drugs on megakaryocytic differentiation.
- To summarize the molecular mechanisms of phytomedicines in promoting MK differentiation.
- To provide evidence for botanical treatments of thrombocytopenia and related diseases.
Main Methods:
- Comprehensive literature search of PubMed, Web of Science, and Google Scholar.
- Review focused on studies published between 1994 and 2022.
- Analysis of documented effects of botanical drugs on MK differentiation in vivo.
Main Results:
- Numerous botanical drugs demonstrate the ability to induce megakaryocytic differentiation.
- Specific phytomedicines have shown potential in improving myelosuppression and erythroleukemia.
- The review identifies key botanical agents and their mechanisms influencing MK development.
Conclusions:
- Botanical drugs represent a viable therapeutic strategy for thrombocytopenia and associated blood disorders.
- Understanding the molecular mechanisms of phytomedicines can guide future drug development.
- Further research into botanical treatments for blood diseases is warranted.
More Related Videos
14:30Immunophenotyping and Cell Sorting of Human MKs from Human Primary Sources or Differentiated In Vitro from Hematopoietic Progenitors
Published on: August 7, 2021
06:57Leukodepletion Filters-Derived CD34+ Cells As a Cell Source to Study Megakaryocyte Differentiation and Platelet Formation
Published on: May 20, 2021
